Apollo Hospitals clarified its Apollo Healthtech Scheme, detailing promoter group director nomination rights tied to shareholding tiers (e.g., Nil below 10%, up to 5 for 35%+). This enhances governance clarity post-listing, aiming to unlock shareholder value.